Olink Proteomics

Olink Proteomics AB specializes in human protein biomarker discovery, offering a range of products and services designed to facilitate scientific research. The company develops multiplex immunoassay panels that enable the identification of multiple proteins and aid in disease detection. Their product portfolio includes various biomarker assays targeting conditions such as cardiovascular diseases, neurology, inflammation, and oncology. Notably, Olink provides panels focused on both low- and high-abundance biomarkers, as well as an oncology panel analyzing 92 protein biomarkers related to cancer. Additionally, the company offers a Mouse Exploratory panel for murine protein discovery and an organ damage panel that identifies proteins linked to organ harm. Olink employs its proprietary Proximity Extension Assay technology, which allows for streamlined research from discovery through clinical trials to diagnostics. The company operates from Uppsala, Sweden, with an additional office in Watertown, Massachusetts, serving clients across regions including the United States, China, and Europe.